Literature DB >> 7957408

X-linked adrenoleukodystrophy in patients with idiopathic Addison disease.

P Jorge1, D Quelhas, P Oliveira, R Pinto, A Nogueira.   

Abstract

UNLABELLED: The two main causes of primary adrenal disease are tuberculosis and auto-immune adrenal destruction. The latter is responsible for about 70% of the cases of primary adrenal insufficiency (Addison disease). Commonly referred to as a rare cause of adrenal failure is X-linked adrenoleukodystrophy (ALD), a demyelinating peroxisomal disorder affecting 1: 20,000 Caucasian males. Albeit primary adrenal insufficiency is a rare entity per se, we decided to study patients with idiopathic Addison disease and establish the frequency of ALD as a cause of adrenal insufficiency. The biochemical defect of ALD was found in 5 out of 24 patients. The small number of cases in our series led us to include in our analysis the published results of two other groups of investigators. This analysis indicates that the proportion of cases in which Addison disease is attributable to ALD is age dependent. It is highest when the adrenal insufficiency manifests before 15 years. This study clearly demonstrates that the proportion of ALD in patients presenting primary adrenal insufficiency has been under-estimated.
CONCLUSION: Addison disease manifesting during the first decade of life has a high likelihood of being the first sign of X-linked adrenoleukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957408     DOI: 10.1007/BF02190668

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  A human skin culture technique used for cytological examinations.

Authors:  D G HARNDEN
Journal:  Br J Exp Pathol       Date:  1960-02

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  Screening of patients with hereditary spastic paraparesis and Addison's disease for adrenoleukodystrophy/adrenomyeloneuropathy.

Authors:  B H Holmberg; E Hägg; M Duchek; L Hagenfeldt
Journal:  Acta Neurol Scand       Date:  1992-02       Impact factor: 3.209

4.  Adrenomyeloneuropathy presenting as Addison's disease in childhood.

Authors:  A Sadeghi-Nejad; B Senior
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

5.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

6.  Familial X-linked Addison disease as an expression of adrenoleukodystrophy (ALD): elevated C26 fatty acid in cultured skin fibroblasts.

Authors:  B P O'Neill; H W Moser; K M Saxena
Journal:  Neurology       Date:  1982-05       Impact factor: 9.910

7.  Characterization of X-linked adrenoleukodystrophy in different biological specimens from ten Portuguese families.

Authors:  P Jorge; D Quelhas; A Nogueira
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 8.  Adrenoleukodystrophy.

Authors:  H W Moser; A Bergin; S Naidu; P W Ladenson
Journal:  Endocrinol Metab Clin North Am       Date:  1991-06       Impact factor: 4.741

9.  Conclusive evidence that very-long-chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblasts.

Authors:  B S Jakobs; R J Wanders
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

10.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.

Authors:  J Mosser; A M Douar; C O Sarde; P Kioschis; R Feil; H Moser; A M Poustka; J L Mandel; P Aubourg
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

View more
  5 in total

Review 1.  X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.

Authors:  B M van Geel; J Assies; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease.

Authors:  M D Ronghe; J Barton; P E Jardine; E C Crowne; M H Webster; M Armitage; J T Allen; C G Steward
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

3.  X-linked adrenoleukodystrophy presenting as Addison's disease.

Authors:  Bernhard Kaspar Morell; Jens Teichler; Kemal Budak; Jörg Vollenweider; Vojtech Pavlicek
Journal:  BMJ Case Rep       Date:  2010-05-13

4.  Clinical profile of adrenoleukodysrophy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Shashank R Joshi; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

Review 5.  Therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser
Journal:  NeuroRx       Date:  2006-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.